Adverse Drug Reaction Bulletin
SJR0.194
US
USJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.194 | Q4 | 26.6% | |
| 2024 | — | — | 0.196 | Q4 | 30.0% | |
| 2023 | — | — | 0.126 | Q4 | 18.8% | |
| 2022 | — | — | 0.126 | Q4 | 22.6% | |
| 2021 | — | — | 0.124 | Q4 | 24.4% | |
| 2020 | — | — | 0.101 | Q4 | 0.0% | |
| 2019 | — | — | 0.101 | Q4 | 5.7% | |
| 2018 | — | — | 0.212 | Q3 | 37.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
0044-6394
ISSN
2159-7774
country
UScoverage
1970, 1973-2025